Kezar Life Sciences

Price & Volume

Stats

52W Range	$3.53-$8.94
Market Cap	$32.2M
Shares Short	762,155

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	-$54M
Diluted EPS	-$9.70

News

Yahoo Finance • 2 months ago

Highlights – June Quarter 2025

Yahoo Finance • 3 months ago

Kezar Life Sciences stock gains after FDA lifts partial clinical hold

Yahoo Finance • 2 years ago

Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Yahoo Finance • 3 years ago

Kezar Life Sciences Reports Fourth Quarter and Year End 2022 Financial Results and Provides Business Update

About

CEO	Dr. Christopher J. Kirk Ph.D.
CFO	Mr. Marc L. Belsky CPA
Address	4000 Shoreline Court, South San Francisco, CA, United States, 94080
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	55